INSY - INSYS Therapeutics, Inc.

NasdaqGM - NasdaqGM Delayed price. Currency in USD
7.59
-0.20 (-2.57%)
At close: 4:00PM EST
Stock chart is not supported by your current browser
Previous close7.79
Open7.82
Bid7.75 x 5000
Ask7.93 x 200
Day's range7.54 - 7.97
52-week range4.10 - 15.02
Volume430,714
Avg. volume1,669,759
Market cap556.473M
Beta2.19
PE ratio (TTM)N/A
EPS (TTM)-2.57
Earnings date2 Apr 2018 - 6 Apr 2018
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est9.80
Trade prices are not sourced from all markets
  • Stocks give up early gains, Trump signs budget bill
    Yahoo Finance12 days ago

    Stocks give up early gains, Trump signs budget bill

    Yahoo Finance's LIVE market coverage and analysis of stocks and bonds begins each day at 11:45 a.m. ET.

  • Globe Newswire22 days ago

    INSYS Therapeutics Adds Two New Executives to Senior Management Team

    VP of Human Resources, Carol Summersgill; VP of Clinical Development, Dr. Ahmed Elkashef

  • Why Marijuana and Cryptocurrency Investments Differ
    Market Realist23 days ago

    Why Marijuana and Cryptocurrency Investments Differ

    In the earlier part of this series, we briefly discussed why investors have recently rushed into cryptocurrencies and marijuana. In this part, we’ll discuss the difference between these investment opportunities, starting with the marijuana industry (MJX). Businesses exist to provide value to an end user, and marijuana’s end use has been fairly well-established. There has been an established market for medical marijuana in several countries.

  • What Vermont Can Learn from Washington’s Marijuana Tax
    Market Realist29 days ago

    What Vermont Can Learn from Washington’s Marijuana Tax

    In the previous article in this series, we saw that Vermont decriminalized recreational marijuana on January 22, 2018. With no legality covering the sale of marijuana and no tax revenues from these sales, what would motivate Vermont to legalize recreational marijuana?

  • Vermont Legalizes Recreational Marijuana on January 22, 2018
    Market Realist29 days ago

    Vermont Legalizes Recreational Marijuana on January 22, 2018

    On January 22, 2018, Vermont decriminalized the possession of marijuana for adults 21 and older. With increasing attention on the legalization of recreational marijuana in recent months, Vermont became the ninth state in the US to legalize marijuana for recreational purposes. This move comes almost six years after recreational marijuana became legal in Colorado and Washington.

  • The Other Side of Legalizing Recreational Marijuana
    Market Realist29 days ago

    The Other Side of Legalizing Recreational Marijuana

    While marijuana legalization for recreational use is just gaining attention around the world, it’s also facing strong opposition. According to some, legalizing marijuana will just increase substance abuse. Some groups are concerned that legalizing marijuana would make it even easier for young people to access the drug.

  • What a Country Could Gain from Legalizing Recreational Marijuana
    Market Realist29 days ago

    What a Country Could Gain from Legalizing Recreational Marijuana

    In the previous part of this series, we saw how the legalization of recreational marijuana could create related business opportunities. In this part, we’ll discuss the potential upside of recreational marijuana for a country like Canada. According to Deloitte, recreational marijuana alone could be a $5 billion industry initially, and it could go as high as $8.7 billion.

  • The Marijuana Ecosystem’s Potential Business Opportunities
    Market Realist29 days ago

    The Marijuana Ecosystem’s Potential Business Opportunities

    In the previous part of this series, we discussed Constellation Brands’ (STZ) investment in the marijuana industry. Given that legislative approval is the strongest driving factor behind the boost in the marijuana industry, companies have rushed to capitalize on the wave. Below, we discuss some of the business opportunities that could develop as a result of marijuana legalization.

  • Is Investment in the Marijuana Space Picking Up?
    Market Realistlast month

    Is Investment in the Marijuana Space Picking Up?

    In the previous part of this series, we saw that the alcohol industry could expect marijuana legalization for recreational purposes as an extension to their growth strategy. With too much confusion surrounding the legalities of the marijuana industry, some seasoned players appear highly optimistic about the future of recreational marijuana. Late last year, Constellation Brands (STZ) agreed to acquire a 9.9% stake in the Canada-based Canopy Growth for about $191.3 million.

  • The Motivation for Recreational Marijuana Consumption
    Market Realistlast month

    The Motivation for Recreational Marijuana Consumption

    In this part, we look at the secondary use of marijuana, recreational use. In mid-2018, Canada is expected to make marijuana legal for recreational use. This outlook has been driving stocks such as Aurora Cannabis (ACB.TO), Canopy Growth (WEED.TO), Aphria (APH.TO), and MedReleaf (LEAF.TO) to new highs.

  • Why the Medical Marijuana Industry Is Growing
    Market Realistlast month

    Why the Medical Marijuana Industry Is Growing

    Must-Knows before Investing in the Marijuana Industry

  • How Marijuana Acceptance Is Evolving Globally
    Market Realistlast month

    How Marijuana Acceptance Is Evolving Globally

    It’s fascinating to see how the marijuana landscape around the world has evolved in the last three years. According to Canopy Growth (WEED.TO), Canada, Israel, the Czech Republic, Uruguay, and the Netherlands “established federally legal cannabis access regimes” in 2014. Globally, the acceptance of marijuana evolved further in 2017 with more countries either legalizing cannabis access at a federal level or exploring the possibility of legalizing cannabis.

  • Must-Knows before Investing in the Marijuana Industry
    Market Realistlast month

    Must-Knows before Investing in the Marijuana Industry

    Must-Knows before Investing in the Marijuana IndustryInvesting in marijuana

  • What Are Insys Therapeutics’ Top Priorities?
    Market Realistlast month

    What Are Insys Therapeutics’ Top Priorities?

    Insys (INSY) is taking strategic steps to restore stakeholder confidence. The company aims to achieve one NDA (or new drug application) per year over the next five years. Insys is targeting treatments for orphan diseases, neurological diseases like pediatric epilepsy, genetic conditions like Prader-Willi syndrome, and treatments for secondary allergic reactions, anorexia, and products for opioid overdose.

  • How Investors Can Access the Marijuana Industry
    Market Realistlast month

    How Investors Can Access the Marijuana Industry

    Should You Jump on the Marijuana Bandwagon? Investors interested in accessing the marijuana industry have several options. In the US, Scotts Miracle-Gro (SMG) has invested in companies that are positioned to serve the cannabis market.

  • Insys Has Legal Issues Galore
    Market Realistlast month

    Insys Has Legal Issues Galore

    In December 2016, the U.S. Attorney’s Office for the District of Massachusetts issued an indictment against six former Insys (INSY) employees, which included the company’s former president, CEO, and director Michael Babich. This indictment was on charges including racketeering conspiracy, conspiracy to commit mail fraud, conspiracy to commit wire fraud, and conspiracy to violate the anti-kickback statute.

  • Why Canada May Be Legalizing Cannabis for Recreational Use This Year
    Market Realistlast month

    Why Canada May Be Legalizing Cannabis for Recreational Use This Year

    Should You Jump on the Marijuana Bandwagon?

  • What’s behind Insys Therapeutics’ Legal Tangles?
    Market Realistlast month

    What’s behind Insys Therapeutics’ Legal Tangles?

    Thus, interaction with government agencies occurs regularly. Insys (INSY) has been a part of several government investigations recently. Insys received a subpoena in December 2013 from the inspector general of HHS for an investigation of potential violations that involved HHS programs.

  • A Look at Insys Therapeutics’ Financial Performance
    Market Realistlast month

    A Look at Insys Therapeutics’ Financial Performance

    Insys’s (INSY) net revenues decreased from $57.7 million in 3Q16 to $30.7 million in 3Q17, which was attributable to a decrease in Subsys sales. As a result, the gross profit of the company decreased to $23.1 million in 3Q17 as compared with $53 million for 3Q16. The general and administrative expenses of the company decreased to $15.7 million in 3Q17 as compared with $17.7 million for 3Q16.

  • Gauging Marijuana Risk: The Potential Investment Blowback
    Market Realistlast month

    Gauging Marijuana Risk: The Potential Investment Blowback

    Should You Jump on the Marijuana Bandwagon? Investing in the marijuana industry—at least in its current stage in the US—certainly comes with its own set of risks. In the preceding part of this series, we discussed how the marijuana plant contains CBD (cannabidiol), which is used for medicinal (XLV) purposes.

  • What Analysts Recommend for Insys Therapeutics and Peers
    Market Realistlast month

    What Analysts Recommend for Insys Therapeutics and Peers

    What to Expect from Insys Therapeutics in 2018Company overview

  • The Arrival of Marijuana
    Market Realistlast month

    The Arrival of Marijuana

    Should You Jump on the Marijuana Bandwagon?

  • Should You Jump on the Marijuana Bandwagon?
    Market Realistlast month

    Should You Jump on the Marijuana Bandwagon?

    Should You Jump on the Marijuana Bandwagon?Interest in the pot industry

  • Globe Newswirelast month

    Factors of Influence in 2018, Key Indicators and Opportunity within Insys Therapeutics, LGI Homes, Steelcase, AtriCure, Alliance Holdings GP, and Digital Turbine — New Research Emphasizes Economic Growth

    NEW YORK, Jan. 08, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Insys Therapeutics, Inc. (NASDAQ:INSY), LGI Homes, Inc. (NASDAQ:LGIH), Steelcase Inc. (NYSE:SCS), AtriCure, Inc. (NASDAQ:ATRC), Alliance Holdings GP, L.P. (NASDAQ:AHGP), and Digital Turbine, Inc. (NASDAQ:APPS), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

  • Your 2018 Guide to Investing in Marijuana Stocks
    Motley Foollast month

    Your 2018 Guide to Investing in Marijuana Stocks

    What you really need to know about buying marijuana stocks this year.

By using Yahoo you agree that Yahoo and partners may use Cookies for personalisation and other purposes